Artificial Cell Technologies, Inc.

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypeptides. Our long term vision is to commercialize biotechnology applications for successively more sophisticated versions of an artificial bionanomachine: the artificial cell. ACT was founded to achieve this artificial cell vision by commercializing biomedical applications of our proprietary polypeptide nanostructure technology platform, starting with one of the simplest of human cells, the red blood cell. ACT’s technology platform includes proprietary methods for manufacturing custom-designed polypeptide films and microcapsules with controlled, tunable biological, chemical, and physical properties.

Contact Details: 5 Science Park Suite 13 New Haven Connecticut 06511 United States of America Tel: 203-772-3430 Fax: 203-567-8073 Email: WWW: www.artificialcelltech.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 478 times since April 2007, the link to the organisation's website has been followed 68 times

Recent Search Terms used to find this page: artificial cell technologies | quotes on artificial cell technologies | Artificial Cell Technologies Inc. investors | artificial cell technologies | artificial cell | artificial cell tech inc | artificial cell tech inc. | artificial cell | artificial cell technology | artificial cell technologies inc accounts | .

Search for more companies in New Haven

Search for more companies in Connecticut

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Artificial Cell Technologies, Inc.